Public Comments to Agencies
CCAGW Leads Coalition In Supports FCC's Proposed TVWS Rule
The proposed TVWS rule is a leap forward for those whose lives will be improved by this technology, and the coalition urges its adoption.
CAGW Files Reply Comments with the FCC in the 5.9 GHz Proceeding
CAGW has long maintained that public resources like the 5.9 GHz band should be maximized to their fullest potential.
Coalition Submits Comments to CEQ on Proposed Updated NEPA Regulations
CCAGW joins coalition with 10 other free market groups in support of the CEQ's Propsed Updated Regulations for implementing NEPA.
CAGW Submits Comments to FDA on Drug Importation Proposed Rule
Comments to the Food and Drug Administration on Proposed Rule for Importing Drugs from Canada
CAGW Submits Comments to FCC on 5.850-5.925 GHz Band Usage
CAGW offers comments supporting the FCC's NPRM to expand and enhance the use of the 5.850 – 5.925 GHz spectrum band.
Comment to FDA on Draft Guidance for Importation of Certain Drugs
Citizens Against Government Waste's Comment on Draft Guidance: Importation of Certain Food and Drug Administration-Approved Human Prescription Drugs, Including Biological Products
Comment to CMS - Medicaid Fiscal Accountability Regulation (MFAR)
Medicaid is a federal and state funded program but is administered by the states.
Coalition Comments on Biosimilar and Interchangeable Insulin Guidance
CAGW and coalition partners share the FDA's deep commitment to the development of a robust biosimilars market and appreciate the Agency’s work to develop an efficient approval pathway for biosimilars to bring savings and access to America’s patients.
CAGW Submits Comments to CMS on Transparency Rule
CAGW has long advocated for more market forces to be used in the U.S. healthcare system.
Coalition Urges Significant Changes to Proposed Commerce Rule
Coalition of taxpayer and consumer advocacy groups urges signficant changes to proposed Commerce rule that would grant broad, undefined powers to the deparment over small businesses.
CAGW Writes to the Food and Drug Administration on Required Warnings for Cigarette Packages and Advertisements
CAGW writes concerns to the Food and Drug Administration about label warnings for cigarette packages and advertisements.
CAGW Submits Comments to Bureau of Consumer Financial Protection on Payday Lending Rule
May 14, 2019 The Honorable Kathy Kraninger Director Bureau of Consumer Financial Protection 1700 G Street, NW Washington, D.C., 20552 Dear Director Kraninger: